Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP)

AIDS Education and Prevention

Volumn 24, Issue 5, 2012, Pages 408-421

  Smith, Dawn K ^a   Toledo, Lauren ^a,b   Smith, Donna Jo ^c   Adams, Mary Anne ^c   Rothenberg, Richard ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b IDF International in Atlanta ^*  (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE TO AIDS; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MALE; MALE HOMOSEXUAL; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; RISK REDUCTION; SEXUAL BEHAVIOR; TRAFFIC AND TRANSPORT;

ADOLESCENT; AFRICAN AMERICANS; ANTI-RETROVIRAL AGENTS; CONSUMER SATISFACTION; FEMALE; FOCUS GROUPS; GEORGIA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERVIEWS AS TOPIC; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREMEDICATION; QUALITATIVE RESEARCH; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; URBAN POPULATION; YOUNG ADULT;

EID: 84867137204     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2012.24.5.408     Document Type: Article

References (21)

1. Baeten, J., & Celum, C., on behalf of The Partners PrEP Study Team. (2011). Antiretroviral pre-exposure prophylaxis for HIV-1 Prevention among heterosexual African men and women: The Partners PrEP Study. Retrieved August 29, 2011, from http://www. hivforum.org/storage/hivforum/documents/ PREPAUG1911/006_celum.pdf
2. Barash, E. A., & Golden, M. (2010). Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle Gay Pride event and sexually transmitted disease clinic. AIDS Patient Care and STDs, 24(11), 689-691. doi: 10.1089/apc.2010.0173
3. Brooks, R. A., Kaplan, R. L., Lieber, E., Landovitz, R. J., Lee, S. J., & Leibowitz, A. A. (2011). Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care, 23(9), 1136-1145. doi: 10.1080/09540121.2011.554528
4. Centers for Disease Control and Prevention. (2011). Extended safety study of tenofovir disoproxil fumarate (TDF) among HIV-1 negative men. Retrieved November 2, 2011, from http://clinicaltrials.gov/ct2/show/NCT 00131677?term=grohskopf&rank=2
5. Centers for Disease Control and Prevention, Smith, D. K., Grant, R. M., Weidle, P. J., Lansky, A., Mermin, J., & Fenton, K. A. (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Reports, 60(3), 65-68.
6. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). (2011). Pre-exposure prophylaxis in YMSM. Retrieved November 2, 2011, from http://clinicaltrials.gov/ct2/show/ NCT01033942?term=ATN+082&rank=1
7. Family Health International. (2011). FEM-PrEP-Update, June 2011. Retrieved August 29, 2011, from http://www.fhi.org/NR/ rdonlyres/e7eqslera65wohq74f5qmeurr4ohgbrofzuxlu3ulos6my24emn6qseom-7eysom3cxrvmbesounwfd/FEMPrEPUpdateJune2011PPT. pdf
8. Golub, S. A., Kowalczyk, W., Weinberger, C. L., & Parsons, J. T. (2010). Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 54(5), 548-555. doi: 10.1097/ QAI.0b013e3181e19a54.
9. Grant, R. M., Lama, J. R., Anderson, P. L., Mc-Mahan, V., Liu, A. Y., Vargas, L., Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587-2599. doi: 10.1056/NEJMoa1011205
10. Kellerman, S. E., Hutchinson, A. B., Begley, E. B., Boyett, B. C., Clark, H. A., & Sullivan, P. (2006). Knowledge and use of HIV preexposure prophylaxis among attendees of minority gay pride events, 2004. Journal of Acquired Immune Deficiency Syndromes, 43(3), 376-377.
11. Koblin, B. A., Murrill, C., Xu, G., Camacho, M., Liu, K. L., Raj-Singh, S., & Torian, L. (2008). Awareness of HIV prevention strategies under development: Word on the street. Journal of Acquired Immune Deficiency Syndromes, 48(2), 232-234. doi: 10.1097/QAI.0b013e318174391e
12. Liu, A. Y., Kittredge, P. V., Vittinghoff, E., Raymond, H. F., Ahrens, K., Matheson, T., Buchbinder, S. P. (2008). Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men. Journal of Acquired Immune Deficiency Syndromes, 47(2), 241-247.
13. Mansergh, G., Koblin, B. A., Colfax, G. N., McKirnan, D. J., Flores, S. A., & Hudson, S. M. (2010). Preefficacy use and sharing of antiretroviral medications to prevent sexually transmitted HIV infection among US men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 55(2), e14-16. doi: 10.1097/QAI.0b013e3181f27616
14. Mehta, S. A., Silvera, R., Bernstein, K., Holzman, R. S., Aberg, J. A., & Daskalakis, D. C. (2011). Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sexually Transmitted Infections, 87(4), 344-348. doi: 10.1136/sti.2010.046284
15. Microbicides Trial Network. (2011). MTN statement on decision to discontinue use of oral tenofovir tablets in VOICE, a major HIV prevention study in women. Retrieved September 29, 2011, from http://www.mtnstopshiv. org/node/3619
16. Mimiaga, M. J., Case, P., Johnson, C. V., Safren, S. A., & Mayer, K. H. (2009). Preexposure antiretroviral prophylaxis attitudes in highrisk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. Journal of Acquired Immune Deficiency Syndromes, 50(1), 77-83. doi: 10.1097/QAI.0b013e31818d5a27
17. Nodin, N., Carballo-Dieguez, A., Ventuneac, A. M., Balan, I. C., & Remien, R. (2008). Knowledge and acceptability of alternative HIV prevention biomedical products among MSM who bare back. AIDS Care, 20(1), 106-115. doi: 10.1080/09540120701449096
18. Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Group, H. I. V. I. S. (2011). Estimated HIV incidence in the United States, 2006-2009. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. PLoS One, 6(8), e17502. doi: 10.1371/journal.pone.0017502
19. Thigpen, M.C., Kebaabetswe, P. M., Smith, D.K., Segolodi, T.M., Soud, F.A., Chillag, K., Chirwa, L.I., Kasonde, M.,. & Paxton, L.A., for the TDF2 Study Group. (2011). Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: Results from the TDF2 study. Retrieved August 29, 2011, from http://www.hivforum.org/storage/ hivforum/documents/PREPAUG1911/004_ paxton.pdf
20. Voetsch, A. C., Heffelfinger, J. D., Begley, E. B., Jafa-Bhushan, K., & Sullivan, P. S. (2007). Knowledge and use of preexposure and postexposure prophylaxis among attendees of Minority Gay Pride events, 2005 through 2006. Journal of Acquired Immune Deficiency Syndromes, 46(3), 378-380. doi: 10.1097/QAI.0b013e3181576874
21. Whiteside, Y. O., Harris, T., Scanlon, C., Clarkson, S., & Duffus, W. (2011). Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. Aids Patient Care and STDs, 25(6), 365-370. doi: 10.1089/apc.2010.0224